JPH0592917A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPH0592917A
JPH0592917A JP3276182A JP27618291A JPH0592917A JP H0592917 A JPH0592917 A JP H0592917A JP 3276182 A JP3276182 A JP 3276182A JP 27618291 A JP27618291 A JP 27618291A JP H0592917 A JPH0592917 A JP H0592917A
Authority
JP
Japan
Prior art keywords
skin
cosmetic
extract
agent
dried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3276182A
Other languages
Japanese (ja)
Other versions
JP3113009B2 (en
Inventor
Tsuneo Nanba
恒雄 難波
Yukio Hattori
征雄 服部
Kenji Shimomura
健次 下村
Masami Nakamura
雅美 中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikimoto Pharmaceutical Co Ltd
Original Assignee
Mikimoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikimoto Pharmaceutical Co Ltd filed Critical Mikimoto Pharmaceutical Co Ltd
Priority to JP03276182A priority Critical patent/JP3113009B2/en
Publication of JPH0592917A publication Critical patent/JPH0592917A/en
Application granted granted Critical
Publication of JP3113009B2 publication Critical patent/JP3113009B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a cosmetic, excellent in beautifying and whitening actions on the skin, capable of smoothing the skin and preventing the skin from roughening and fine winkles from forming and having guaranteed safety. CONSTITUTION:A cosmetic is obtained by including a solvent extract from Fraxini Cortex (a dried bark of Fraxinus japonica Blume) which has been utilized as an antiphlogistic agent, an antidiarrheal agent, an antipyretic agent or a tonic from old times in an amount of 0.00005-5wt.%, preferably 0.005-2wt.% expressed in terms of a dry substance. A hydrophilic organic solvent such as ethanol, methanol, acetone, propylene glycol, glycerol or 1,3-butylene glycol and water alone or a mixed solution is used as the extracting solvent. The above-mentioned extract is capable of producing inhibitory effects on tyrosinase activity and suppressing effects on active oxygen.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は美白作用が高く、皮膚を
滑らかにし、若々しい皮膚を保つ化粧品に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic having a high whitening effect, smoothing the skin and keeping youthful skin.

【0002】[0002]

【従来の技術】秦皮は双子葉植物網、離弁花亜網、もく
せい目、もくせい科のトネリコ属に属するトネリコ(サ
トトネリコ)Fraxinus japonica、ア
オダモ(コバノトネリコ)Fraxinus lanu
ginosa、オオトネリコ(チョウセントネリコ)F
raxinus rhynchophylla等の樹皮
を乾燥したものである。いずれも雌雄異株の落葉樹であ
り、木としては硬いので銃座、野球のバット等に用いら
れている。
2. Description of the Related Art Qin skin is a dicotyledonous net, a leaflet sub net, a mosquito, and a ash belonging to the genus Ash of the family Fraxinus japonica and Aodamo Fraxinus lanu.
ginosa, ash F
The bark of raxinus rhynchophylla or the like is dried. All of them are dioecious deciduous trees, and because they are hard trees, they are used for guns, baseball bats, and the like.

【0003】秦皮は薬用としても用いられ、熱性下痢、
解熱、洗眼剤、強壮剤、消炎症剤として古くから用いら
れている。化粧品としては現在のところ利用されていな
い。これは古くより消炎、下痢止め、解熱、強壮剤とし
て利用されてきた。特開昭61−15834号公報に抗
アレルギー食品として利用されている程度で化粧品とし
ては全く利用されていない。
Qin peel is also used for medicinal purposes, and causes febrile diarrhea,
It has long been used as an antipyretic, eye wash, tonic, and anti-inflammatory agent. Not currently used as cosmetics. It has been used for a long time as an anti-inflammatory, anti-diarrheal, antipyretic and tonic. It is used as an antiallergic food in JP-A-61-15834, but not as a cosmetic at all.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は皮膚に
適用して安全であると共に美白作用があり、皮膚を滑ら
かにし、若々しい皮膚を保ち、かつ皮膚を滑らかに保つ
化粧品を提供することにある。
DISCLOSURE OF THE INVENTION The object of the present invention is to provide a cosmetic which is safe and has a whitening effect when applied to the skin, smoothes the skin, keeps youthful skin, and keeps the skin smooth. Especially.

【0005】[0005]

【課題を解決するための手段】本発明者らは、入手が容
易である植物の抽出物を数多く試験したところ、秦皮の
抽出物が化粧料として非常に有効であることを見い出
し、本発明に到達した。
Means for Solving the Problems The inventors of the present invention tested a number of plant extracts that are easily available, and found that the extract of Qin peel was very effective as a cosmetic composition. Arrived

【0006】すなわち、本発明は秦皮の溶媒抽出物を含
む化粧料である。
That is, the present invention is a cosmetic containing a solvent extract of Qin peel.

【0007】トネリコ等の樹皮を乾燥した秦皮は、すで
に生薬として、医薬品(内用薬)原料として販売されて
いるし、且つ日本の山野で容易に自生したものを採取で
きるのである。
Qin bark obtained by drying the bark of ash etc. is already sold as a crude drug and as a raw material for medicines (internal drug), and it is possible to collect the one naturally grown in the mountains of Japan.

【0008】これを親水性有機溶媒及び水の単独或いは
混合溶液で抽出する。親水性有機溶媒としては、エタノ
ール、メタノール、アセトン、プロピレングリコール、
グリセリン、1,3ブチレングリコール等を用いる。
This is extracted with a hydrophilic organic solvent and water alone or as a mixed solution. As the hydrophilic organic solvent, ethanol, methanol, acetone, propylene glycol,
Glycerin, 1,3 butylene glycol or the like is used.

【0009】この物質を他の化粧品原料例えばスクワラ
ン、ホホバ油等の液状油、ミツロウ、セチルアルコール
等の固体油、各種の活性剤、グリセリン、1,3ブチレ
ングリコール等の保湿剤や各種薬剤等を添加してさまざ
まな剤形の化粧料を調整することができる。例えばロー
ション、クリーム、乳液、パック等で目的に応じて利用
形態を考えればよい。秦皮の抽出物は配合する剤形、製
品の目的によって、あるいは共存させる薬剤の有無によ
って効果の発現は異なるのであるが、乾燥物換算にし
て、0.00005〜5重量%好ましくは0.005〜
2重量%が適当である。
This substance can be used as other cosmetic raw materials such as liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, humectants such as glycerin and 1,3 butylene glycol, and various drugs. It can be added to adjust various dosage forms of cosmetics. For example, a lotion, a cream, a milky lotion, a pack or the like may be used depending on the purpose. The effect of the extract of Qin peel varies depending on the dosage form to be blended, the purpose of the product, or the presence or absence of a coexisting drug, but in terms of dry matter, 0.00005 to 5% by weight, preferably 0.005 to 5% by weight.
2% by weight is suitable.

【0010】[0010]

【実施例】以下の実施例により、本発明をさらに具体的
に説明するが、本発明は、この実施例によって何等限定
されるものではない。
EXAMPLES The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.

【0011】(製造例1)乾燥した秦皮を20gにメタ
ノール200mlを加えて、還流冷却管をつけ、3時間加
熱した。瀘過後凍結乾燥した。
(Production Example 1) 200 g of methanol was added to 20 g of dried Qin husk, and a reflux condenser was attached and heated for 3 hours. After filtration, it was freeze-dried.

【0012】(製造例2)乾燥した秦皮を20gに50
%メタノール200mlを加えて、還流冷却管をつけ、3
時間加熱した。瀘過後凍結乾燥した。
(Production Example 2) 50 g of dried Qin peel was added to 20 g.
Add 200 ml of% methanol, attach a reflux condenser, and 3
Heated for hours. After filtration, it was freeze-dried.

【0013】(製造例3)乾燥した秦皮を20gに精製
水200mlを加えて、還流冷却管をつけ、3時間加熱し
た。瀘過後凍結乾燥した。
(Production Example 3) To 20 g of dried Qin husk, 200 ml of purified water was added, and a reflux condenser was attached, followed by heating for 3 hours. After filtration, it was freeze-dried.

【0014】(製造例4)乾燥した秦皮を20gに50
%エタノール200mlを加えて、10日間放置した。こ
れをこれを瀘過後凍結乾燥した。収量は0.54gであ
った。
(Production Example 4) 50 g of dried Qin peel was added to 20 g.
200 ml of ethanol was added and the mixture was left for 10 days. This was filtered and freeze-dried. The yield was 0.54g.

【0015】(製造例5)乾燥した秦皮を20gにエタ
ノール200mlを加えて、10日間放置した。これを瀘
過後凍結乾燥した。収量は、1.03gであった。
(Production Example 5) 200 g of ethanol was added to 20 g of dried Qin peel and left for 10 days. This was filtered and freeze-dried. The yield was 1.03 g.

【0016】(実施例1)ローション 製造例1の抽出物 1.0 エタノール 80.0 精製水 19.0(Example 1) Lotion Extract of Production Example 1 1.0 Ethanol 80.0 Purified water 19.0

【0017】(実施例2)クリーム A スクワラン 20.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 製造例2の抽出物 1.0 B 精製水 55.9 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 グリセリン 5.0 パラオキシ安息香酸メチル 0.1 AとBをそれぞれ計量し、70℃まで加温し、BにAを
攪拌しつつ徐々に加えたのち、ゆっくり攪拌しつつ30
℃まで冷却した。
Example 2 Cream A Squalane 20.0 Jojoba Oil 5.0 Beeswax 5.0 Cetostearyl Alcohol 2.0 Glycerin Monostearate 1.0 Sorbitan Monostearate 2.0 Extract 1 of Production Example 1 0.0 B Purified water 55.9 Polyoxyethylene (20 E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60 E.O.) Hydrogenated castor oil 1.0 Glycerin 5.0 Methyl paraoxybenzoate 0.1 A and B are weighed individually, heated to 70 ° C., A is gradually added to B with stirring, and then 30 with slow stirring.
Cooled to ° C.

【0018】(実施例3)実施例1の製造例1の秦皮の
抽出物を製造例5の抽出物に替えたもの。
(Example 3) The extract of Qin peel of Production Example 1 of Example 1 was replaced with the extract of Production Example 5.

【0019】(実施例4)実施例2の製造例2の秦皮の
抽出物を製造例3の抽出物に替えたもの。
(Example 4) The extract of Qin peel of Production Example 2 of Example 2 was replaced by the extract of Production Example 3.

【0020】(実施例5)実施例2の製造例2の秦皮の
抽出物を製造例4の抽出物に替えたもの。
(Example 5) A product obtained by replacing the extract of Qin peel of Production Example 2 of Example 2 with the extract of Production Example 4.

【0021】(チロシナーゼ活性阻害率の測定) (試験方法)マックルバルン(Mcllvaln)緩衝液0.9m
l、1.66mM チロシン(Tyrosine)溶液1.0ml、前
記試料(抽出乾燥物)をエタノールに溶解させ、水を加
えた後、エバポレータでエタノールを除去した後、0.
1重量(乾燥物)/容量%に調整した規定濃度水溶液
1.0mlをスクリューバイアルにとり、37℃恒温水槽
中で5分以上加温した。チロシナーゼ溶液(Sigma社製、
マッシュルーム由来、914ユニット/ml)0.1mlを
加え、37℃恒温水槽中で保温し、10分後に475nm
で吸光度を測定した。対照として、上記試料液のかわり
に純水を加え同様に測定した。
(Measurement of Tyrosinase Activity Inhibition Rate) (Test Method) Mcllvaln Buffer Solution 0.9 m
1.0 ml of a 1.66 mM Tyrosine solution and the above sample (extracted dried product) were dissolved in ethanol, water was added, and ethanol was removed by an evaporator.
1.0 ml of a normal concentration aqueous solution adjusted to 1 weight (dry matter) / volume% was placed in a screw vial and heated in a 37 ° C. constant temperature water tank for 5 minutes or more. Tyrosinase solution (Sigma,
Mushroom-derived, 914 units / ml) 0.1 ml was added and kept in a 37 ° C constant temperature water bath, and after 10 minutes 475 nm
The absorbance was measured with. As a control, pure water was added instead of the sample solution and the same measurement was performed.

【0022】(計算式) A:試料検体の吸光度 B:対照の吸光度 P:試料検体の着色による吸光度(3倍希釈) チロシナーゼ活性阻害率(%) ={B−(A−P)}/B
×100
(Calculation formula) A: Absorbance of sample specimen B: Absorbance of control P: Absorbance due to coloring of sample specimen (3-fold dilution) Tyrosinase activity inhibition rate (%) = {B- (AP)} / B
× 100

【0023】[0023]

【表1】 [Table 1]

【0024】(活性酸素抑制効果の測定)大気中には2
1%の酸素があり、これがないと生物(嫌気性のものを
除く)は存在しえない。しかし、酸素は紫外線や酵素等
の影響を受けて活性酸素になる。活性酸素は脂肪酸を酸
化し過酸化物を生成させる。生体の生体膜のリン脂質も
酸化させ、障害を与える。且つ、生成した過酸化物と活
性酸素はDNAに損傷を与え、老化を促進すると言われ
ている。また、チロシンからメラニンを作る機構にも影
響を与え皮膚の黒化にも関与している。この活性酸素を
抑制することは皮膚にとって重要な、言い換えれば化粧
料に求められる重要な要素の一つである。
(Measurement of Active Oxygen Suppression Effect) 2 in the atmosphere
There is 1% oxygen, without which no organisms (except anaerobic) can exist. However, oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes. Active oxygen oxidizes fatty acids and produces peroxides. It also oxidizes and damages the phospholipids of biological membranes in the body. Moreover, it is said that the generated peroxide and active oxygen damage DNA and accelerate aging. It also affects the mechanism of melanin production from tyrosine and is involved in skin darkening. Suppressing this active oxygen is one of the important factors required for the skin, in other words, for cosmetics.

【0025】活性酸素を抑制する効果を測定する方法は
各種あるが、今回以下の方法を利用した。 pH7.8 50mM リン酸カリウム緩衝液(1.3mM DETAPAC 含有) 133ml 40 unit/ml カタラーゼの上記のリン酸カリウム緩衝液 5ml 2mM ニトロブルーテトラゾリウムの上記のリン酸カリウム緩衝液 5ml 1.8mM キサンチンの上記のリン酸カリウム緩衝液 17ml 160ml 上の試薬の混合物を2.4ml、検体(前記抽出乾燥物
0.1wt/v%水溶液)を0.3ml加えて、キサンチンオ
キシナーゼ(予め検体を水とし、実験するとき、吸光度
が1分当り0.02前後上昇するように上記のリン酸カ
リウム緩衝液で調整しておく)液を0.3ml加えて直ち
に吸光度(560nm)を測定する。(測定は2分位と
し、直線性を確認する。)
A method for measuring the effect of suppressing active oxygen is
There are various types, but the following method was used this time. pH 7.8 50 mM potassium phosphate buffer (containing 1.3 mM DETAPAC) 133 ml 40 unit / ml Catalase above potassium phosphate buffer 5 ml 2 mM nitroblue tetrazolium above potassium phosphate buffer 5 ml17 ml of the above potassium phosphate buffer solution containing 1.8 mM xanthine  2.4 ml of a mixture of the reagents above 160 ml, sample (the above-mentioned dried extract)
0.1 wt / v% aqueous solution), add 0.3 ml, and
Xinase (absorbance when using water as the sample in advance)
The above-mentioned phosphoric acid
Immediately after adding 0.3 ml of the solution)
Then, the absorbance (560 nm) is measured. (Measurement is 2 quantiles
And check the linearity. )

【0026】 計算式 阻害率=(A−B)/A×100 但し、A:検体を水としたときの1分当りの吸光度の変
化 B:検体の1分当りの吸光度の変化 その結果を50%活性酸素生成阻害濃度(%)で表し
て、表2に示す。
Calculation formula Inhibition rate = (A−B) / A × 100 where A: change in absorbance per minute when the sample is water B: change in absorbance per minute of the sample The result is 50 It is shown in Table 2 in terms of% active oxygen production inhibition concentration (%).

【0027】[0027]

【表2】 [Table 2]

【0028】(使用テスト)女性5名づつの顔面を左右
に分け、一方を実施例、もう一方を比較例として、毎
日、1回以上使用してもらって3カ月後、アンケートし
た。なお、15名を3班にわけ、表3の試料を使って実
験した。
(Usage Test) Faces of 5 women were divided into right and left sides, one of which was used as an example and the other of which was used as a comparative example once a day for one or more times, and a questionnaire was taken after 3 months. In addition, 15 people were divided into 3 groups and an experiment was performed using the samples in Table 3.

【表3】 判定基準は以下のようでアンケートの結果をまとめた
のが以下の表4である。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3
[Table 3] The criteria are as follows, and the results of the questionnaire are summarized in Table 4 below. Example is very good 3 Example is considerably good 2 Example is slightly good 1 No difference 0 Comparative example is slightly good -1 Comparative example is quite good -2 Comparative example Is very good -3

【0029】[0029]

【表4】 [Table 4]

【0030】[0030]

【発明の効果】本発明の化粧料は、美白作用に優れ、且
つ皮膚を滑らかにし、肌荒を防ぎ、小皺を防止する効果
がある。古くより生薬として内用されており、従って安
全性については保証されている。
The cosmetic composition of the present invention has an excellent whitening effect, and has effects of smoothing the skin, preventing rough skin, and preventing wrinkles. It has been used internally as a crude drug since ancient times and is therefore guaranteed to be safe.

─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成3年12月10日[Submission date] December 10, 1991

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0023[Name of item to be corrected] 0023

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0023】[0023]

【表1】 [Table 1]

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0027[Name of item to be corrected] 0027

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0027】[0027]

【表2】 [Table 2]

【手続補正3】[Procedure 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0028[Correction target item name] 0028

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0028】(使用テスト)女性5名づつの顔面を左右
に分け、一方を実施例、もう一方を比較例(実施例1、
2より製造例を除いたものを比較例1、2とした)とし
て、毎日、1回以上使用してもらって3カ月後、アンケ
ートした。なお、15名を3班にわけ、表3の試料を使
って実験した。
(Usage test) The faces of five women were divided into left and right sides, one of which was an example and the other was a comparative example (example 1,
Comparative Examples 1 and 2 were obtained by removing the production example from 2)
I had them use it more than once every day, and after 3 months I conducted a questionnaire. In addition, 15 people were divided into 3 groups and an experiment was performed using the samples in Table 3.

【表3】 判定基準は以下のようでアンケートの結果をまとめた
のが以下の表4である。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3
[Table 3] The criteria are as follows, and the results of the questionnaire are summarized in Table 4 below. Example is very good 3 Example is considerably good 2 Example is slightly good 1 No difference 0 Comparative example is slightly good -1 Comparative example is quite good -2 Comparative example Is very good -3

───────────────────────────────────────────────────── フロントページの続き (72)発明者 服部 征雄 富山県富山市五福末広町2556−4 2− 203 (72)発明者 下村 健次 三重県伊勢市船江3−16−32 (72)発明者 中村 雅美 三重県鳥羽市池上町6−32 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Masao Hattori 2556-4-22-203 Gofuku Suehiro-cho, Toyama City, Toyama Prefecture (72) Inventor Kenji Shimomura 3-16-32 Funae, Ise City, Mie Prefecture (72) Inventor Nakamura Masami 6-32 Ikegami Town, Toba City, Mie Prefecture

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 秦皮の溶媒抽出物を含む化粧料。1. A cosmetic containing a solvent extract of Qin peel.
JP03276182A 1991-09-30 1991-09-30 Whitening cosmetics Expired - Fee Related JP3113009B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03276182A JP3113009B2 (en) 1991-09-30 1991-09-30 Whitening cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03276182A JP3113009B2 (en) 1991-09-30 1991-09-30 Whitening cosmetics

Publications (2)

Publication Number Publication Date
JPH0592917A true JPH0592917A (en) 1993-04-16
JP3113009B2 JP3113009B2 (en) 2000-11-27

Family

ID=17565860

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03276182A Expired - Fee Related JP3113009B2 (en) 1991-09-30 1991-09-30 Whitening cosmetics

Country Status (1)

Country Link
JP (1) JP3113009B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100732564B1 (en) * 2005-08-22 2007-06-27 한불화장품주식회사 Cosmetic composition containing extract of fraxinus chinensis
KR101497501B1 (en) * 2012-12-04 2015-03-02 주식회사 코리아나화장품 Cosmetic composition comprising the extract of Fraxinus mandshurica RUPR. as active ingredient
KR20190092686A (en) * 2018-01-31 2019-08-08 오산대학교 산학협력단 Composition for skin-whitening containing mixed extracts as a active ingredients, and manufacturing method for composition and cosmetic composition
CN113827518A (en) * 2021-09-27 2021-12-24 广州市科能化妆品科研有限公司 Composition for inhibiting melanin generation, whitening composition, whitening emulsion and preparation thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100732564B1 (en) * 2005-08-22 2007-06-27 한불화장품주식회사 Cosmetic composition containing extract of fraxinus chinensis
KR101497501B1 (en) * 2012-12-04 2015-03-02 주식회사 코리아나화장품 Cosmetic composition comprising the extract of Fraxinus mandshurica RUPR. as active ingredient
KR20190092686A (en) * 2018-01-31 2019-08-08 오산대학교 산학협력단 Composition for skin-whitening containing mixed extracts as a active ingredients, and manufacturing method for composition and cosmetic composition
CN113827518A (en) * 2021-09-27 2021-12-24 广州市科能化妆品科研有限公司 Composition for inhibiting melanin generation, whitening composition, whitening emulsion and preparation thereof

Also Published As

Publication number Publication date
JP3113009B2 (en) 2000-11-27

Similar Documents

Publication Publication Date Title
WO2002053127A1 (en) Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same
JP2003113068A (en) Skin cosmetic
JP3502415B2 (en) Maillard reaction inhibitor
JPH1025238A (en) Preparation for external use for skin
JP5196416B2 (en) Cosmetic composition containing Limnocitrus litoritalis extract
JPH05306214A (en) Cosmetic
JP2600036B2 (en) Cosmetics
JP3235922B2 (en) Cosmetics
JP4413387B2 (en) Collagen production promoter, elastase activity inhibitor, collagenase activity inhibitor and skin cosmetic
JPH05124952A (en) Cosmetic
JPH0592917A (en) Cosmetic
JP3235919B2 (en) Cosmetics
JPH0892053A (en) External preparation for skin
JP3545057B2 (en) Cosmetics
JPH0597649A (en) Cosmetic
JPH0597653A (en) Cosmetic
JP2778855B2 (en) Cosmetics
JP2774882B2 (en) Whitening and anti-aging cosmetics
JP4633205B2 (en) Elastase inhibitor and topical skin preparation
JPH11158054A (en) Skin lotion
JP2000212058A (en) Skin cosmetic, active oxygen eliminator, esterase inhibitor, and collagenase inhibitor
JP3547155B2 (en) Active oxygen suppressant
JP2021113172A (en) Peptidyl arginine deiminase 1 expression promoter
JP3792745B2 (en) Tyrosinase inhibitor
JPH05320035A (en) Cosmetic

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees